Not Your Typical Ulcerative Colitis Patient
| Autor: | Teodora SPATARU, Ana STEMATE, Roxana SADAGURSCHI, Lucian NEGREANU |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2024 |
| Předmět: | |
| Zdroj: | Modern Medicine, Vol 31, Iss 1, Pp 79-82 (2024) |
| Druh dokumentu: | article |
| ISSN: | 1223-0472 2360-2473 |
| DOI: | 10.31689/rmm.2024.31.1.79 |
| Popis: | Background: Extraintestinal manifestations (EIMs) of inflammatory bowel diseases (IBDs) are a common and debilitating feature of disease, occurring in up to 40% of patients with IBD. Despite the huge therapeutic progress of the last decade, one must not forget about the side effects that currently available medications might have and the challenges to both patient and physician. Case presentation: We present the case of a 33-year-old woman, that initially was admitted for diffuse abdominal pain, nausea and bloating. After careful investigation she was diagnosed with a drug induced acute pancreatitis, caused by sulfamethoxazole/trimethoprim taken for UTI. Further investigations established a diagnosis of ulcerative colitis. Initial treatment with mesalamine resulted in another acute pancreatitis event that required hospitalization. An anti-TNF therapy with infliximab was started with initial clinical remission but then she developed another adverse reaction, this time paradoxical psoriasis, while having an IBD flare. So, this begged the question, how do we treat a patient that had an adverse reaction to every prior treatment? Conclusion: Developing newer and newer therapies will bring also different possible adverse events that should be carefully diagnosed and managed. |
| Databáze: | Directory of Open Access Journals |
| Externí odkaz: |
|